WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010033074) USE OF A TLR7 AGONIST FOR THE TREATMENT OF CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/033074    International Application No.:    PCT/SE2009/051036
Publication Date: 25.03.2010 International Filing Date: 17.09.2009
IPC:
A61K 31/522 (2006.01), A61P 13/00 (2006.01), A61P 17/00 (2006.01), A61P 35/00 (2006.01), C07D 473/28 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
DAINIPPON SUMITOMO PHARMA CO. LTD [JP/JP]; 2-6-8 Doshomachi Chuo-ku , Osaka (JP) (For All Designated States Except US).
ISOBE, Yoshiaki [JP/JP]; (JP) (For US Only).
MURATA, Masashi [JP/JP]; (JP) (For US Only)
Inventors: ISOBE, Yoshiaki; (JP).
MURATA, Masashi; (JP)
Agent: ASTRAZENECA INTELLECTUAL PROPERTY; AstraZeneca AB S-151 85 Södertälje (SE)
Priority Data:
61/097,934 18.09.2008 US
Title (EN) USE OF A TLR7 AGONIST FOR THE TREATMENT OF CANCER
(FR) UTILISATION D'UN AGONISTE DE TLR7 POUR LE TRAITEMENT DU CANCER
Abstract: front page image
(EN)The invention relates to a novel method of treatment or prophylaxis of cancer, which comprises administering to a patient in need thereof a therapeutically effective amount of a TLR7 agonist of Formula (I), or a pharmaceutically acceptable salt thereof.
(FR)L'invention porte sur un nouveau procédé de traitement ou de prophylaxie du cancer, qui comprend l'administration à un patient nécessitant un tel traitement d'une quantité thérapeutiquement efficace d'un agoniste de TLR7 de formule (I), ou d'un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)